NeoGenomics (NEO) Financial Statements

1,927 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently $1.08B. The company's EPS TTM is $; its P/E ratio is -2.79; NeoGenomics is scheduled to report earnings on April 28, 2026, and the estimated EPS forecast is

lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 727.33M	$ 660.57M	$ 591.64M	$ 509.73M	$ 484.33M
Gross Profit	$ 282.54M	$ 290.10M	$ 244.60M	$ 187.90M	$ 187.06M
Operating Income	$ -66.08M	$ -92.11M	$ -107.74M	$ -157.62M	$ -118.75M
EBITDA	$ 1.75M	$ -1.51M	$ -17.61M	$ -82.33M	$ -65.40M
Net Income	$ -108.03M	$ -78.73M	$ -87.97M	$ -144.25M	$ -8.35M
Balance Sheet
Cash & Short-Term Investments	$ 159.62M	$ 386.84M	$ 415.20M	$ 437.99M	$ 515.39M
Total Assets	$ 1.36B	$ 1.64B	$ 1.68B	$ 1.74B	$ 1.87B
Total Debt	$ 472.28M	$ 605.33M	$ 611.68M	$ 610.93M	$ 612.79M
Net Debt	$ 312.66M	$ 238.32M	$ 269.19M	$ 347.75M	$ 295.96M
Total Liabilities	$ 523.27M	$ 735.70M	$ 739.69M	$ 742.01M	$ 761.50M
Stockholders' Equity	$ 836.56M	$ 902.34M	$ 941.54M	$ 998.02M	$ 1.11B
Cash Flow
Free Cash Flow	$ -21.78M	$ -34.04M	$ -30.70M	$ -96.88M	$ -90.86M
Operating Cash Flow	$ 5.23M	$ 7.02M	$ -1.95M	$ -65.99M	$ -26.72M
Investing Cash Flow	$ -12.34M	$ 12.86M	$ 76.71M	$ 517.00K	$ -632.37M
Financing Cash Flow	$ -200.29M	$ 4.65M	$ 4.55M	$ 11.83M	$ 725.28M

Currency in USD

NeoGenomics Earnings and Revenue History

Income Statement >

NeoGenomics Debt to Assets

Balance Sheet >

NeoGenomics Cash Flow

Cash Flow >

NeoGenomics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >